Moberg Pharma Completes Divestment of Balmex(R) for $4.25 million

STOCKHOLM, April 27, 2018 -- (Healthcare Sales & Marketing Network) -- Moberg Pharma AB (OMX: MOB) has completed the divestment of the Balmex® brand to Randob Labs for a total consideration of $4.25 million plus the inventory value. The divestment re... Biopharmaceuticals, Acquisitions Moberg Pharma, Randob Labs, Balmex
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news